MAINZ BIOMED N.V.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
Netherlands
Business Address
ROBERT KOCH STRASSE 50, MAINZ, 2M, 55129
Mailing Address
ROBERT KOCH STRASSE 50, MAINZ, 2M, 55129
Phone
49 6131 5542860
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
-$16.21M
Net Income
$13.50M
Total Assets
$7.50M
Total Liabilities
$6.00M
Stockholders' Equity
$-2.70
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 25, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 17, 2026 | View on SEC |
| 8-K Current report of material events | March 11, 2026 | View on SEC |
| 3 Initial insider ownership report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 19, 2026 | View on SEC |
| 4 Insider stock transaction report | February 19, 2026 | View on SEC |
| 3 Initial insider ownership report | February 19, 2026 | View on SEC |
Annual Reports
10-K
March 31, 2026
- Strategic pivot from biotech to post-quantum cybersecurity under new name 'Quantum Cyber N.V.'
- Divestiture of ColoAlert business for $2.5 million to address cash constraints
Material Events
8-K
Financial Distress
March 25, 2026
High Impact
- ColoAlert® cancer screening test serves as the primary growth driver.
- Company has a 180-day window until September 16, 2026, to regain compliance.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.